Breaks Categories: News

MondayNov 21, 2022 1:15 pm

NetworkNewsBreaks – Resourcing Tomorrow to Connect Miners with Smart Money, Investors with Under-the-Radar Opportunities

Beacon Events, a renowned producer of conferences for leading companies and seasoned investors, will host the upcoming Mines and Money’s Resourcing Tomorrow event at London’s Business Design Center from Nov. 29 to Dec. 1, 2022. As Europe’s largest and most in-depth mining conference dedicated to global sustainability goals, Resources Tomorrow will cover critical themes of how the mining industry can accelerate the broader energy transition and enable a transformation to a green economy. With more than 2,000 key decision makers scheduled to attend, Resourcing Tomorrow offers the foremost networking platform catering to mining leaders, policymakers, investors, innovators, and educators from…

Continue Reading

MondayNov 21, 2022 1:07 pm

NetworkNewsBreaks – Grapefruit USA Inc. (GPFT) Announces Status Update Regarding DLC Acquisition

Grapefruit USA (OTCQB: GPFT), an innovative California-based cannabiotech company, has announced an update regarding its proposed acquisition of Diagnostic Lab Corporation (“DLC”), a diversified food and agriculture safety company. In August, Grapefruit announced that it was finalizing its due diligence on the DLC acquisition and was in the “final stages” of negotiations regarding financing and structuring of the transaction. That announcement stated that the company expected completion “in the next several weeks.” Today’s update notes that the anticipated transaction and financing process is continuing, with all terms and conditions of financing and structure expected within the next 30 days. “We are…

Continue Reading

MondayNov 21, 2022 12:48 pm

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Focus on Dementia and Diabetes Featured in New Interview

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, was featured in an interview produced by PCG Digital Holdings LLC and published on NewMediaWire. John Docherty, Lexaria’s president and head of research, discussed the company’s efforts to investigate the potential therapeutic utility of its proprietary DehydraTECH(TM)-CBD against dementia and diabetes, two of the world’s largest public health crises. Lexaria recently demonstrated DehydraTECH-CBD’s exceptional safety and tolerability in a human hypertension study, as well as statistically significant lowering of blood pressure over multiple weeks (something that previous studies by others have failed to evidence). Strong connections exist between…

Continue Reading

MondayNov 21, 2022 12:26 pm

NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advancing Research of SPU-21 in Human Synovial Tissue

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced its plans to initiate a pilot study of its novel joint homing peptides targeting rheumatoid arthritis (“RA”), designated as SPU-21, in human synovial tissue surrounding joints and tendons. The three-month study will assess the binding affinity of the peptide in healthy human and RA synovial tissue, with initial data expected during the first quarter of 2023. “SPU-21 was shown to inhibit arthritic progression in a preclinical animal model, so we are proceeding to advance our research into human synovial tissue, where…

Continue Reading

MondayNov 21, 2022 11:34 am

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Schedules Q3 2022 Earnings Call

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that it will host its third quarter 2022 earnings call via webcast at 4:30 p.m. ET on Monday, Nov. 28. During the webcast, Flora management will deliver financial and operational results for the third quarter ended Sept. 30, 2022, and provide updates on the company’s commercial wholesale operations, house of brands and life sciences division strategies. Following the presentation, Flora management will open the call to analysts, media and investors in a Q&A format. Interested parties should visit https://nnw.fm/aPd0I to register for…

Continue Reading

MondayNov 21, 2022 11:16 am

NetworkNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) to Present at the January 2023 Biotech Showcase

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, today announced that its CEO Amir Reichman will present at the upcoming Biotech Showcase conference. The event is slated to take place Jan. 9-11, 2023, in San Francisco in parallel to the J.P. Morgan (“JPM”) 41st Annual Health Care Conference. Reichman will be available to meet potential partners, collaborators and investors. Interested parties should visit https://nnw.fm/yToNl or https://nnw.fm/tkwCW or contact BiondVax Investor Relations at +972-8-930-2529 or [email protected] to request a one-on-one appointment. To view the full…

Continue Reading

MondayNov 21, 2022 11:10 am

NetworkNewsBreaks — DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) to Donate $10K to Meals on Wheels America, Encourages Players to Support Program

DoubleDown Interactive (NASDAQ: DDI), a leading gaming company delivering unique player experiences across a variety of genres, is supporting seniors and ensuring they have food during the holiday season. The company announced plans to donate $10,000 to Meals on Wheels America, the national leadership organization supporting community-based programs across the country to help combat senior hunger and isolation during the holiday season. According to the press release, 1 in 158 seniors in the United States experienced food insecurity in 2020, with an estimated 88% of community-based Meals on Wheels programs being impacted by cost increases and production expenses. DoubleDown is inviting…

Continue Reading

FridayNov 18, 2022 2:26 pm

NetworkNewsBreaks – IBN to Heighten Visibility, Drive Virtual Presence of RHK’s 2022 Disruptive Growth Conference

IBN (“InvestorBrandNetwork”), a multifaceted communications organization with 50+ brands such as InvestorWire, today announced its engagement by RHK Capital (“RHK”) to serve as an official media partner for its upcoming 2022 Disruptive Growth Conference. InvestorWire will also serve as the official newswire for the event slated to take place on Dec. 5-6, 2022, at the Offices of Reed Smith LLP in New York City. The conference will showcase exciting and innovative growth-oriented companies that are poised to disrupt a wide array of sectors, including health care, technology, biotech and electric vehicles. As media sponsor, IBN will leverage its array of…

Continue Reading

FridayNov 18, 2022 2:04 pm

NetworkNewsBreaks – Global Tech Industries Group Inc. (GTII) Announces Upstream Listing Strategy

Global Tech Industries Group (OTCQB: GTII), a Nevada corporation, today announced that it has begun the application process to list its shares on Upstream, a trading app for digital securities and NFTs powered by Horizon Fintex and MERJ Exchange Limited. The move is designed to provide the company the opportunity to access an international, digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and USD, potentially unlocking liquidity and enhancing price discovery. “We are pursuing GTII’s listing as part of a broader effort to bring value to our shareholders and create an entire new…

Continue Reading

FridayNov 18, 2022 10:41 am

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Anticipated $6M Private Placement Funding

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has entered into a securities purchase agreement with two healthcare-focused institutional investors. The agreement outlines plans for the issuance and sale of 1,818,185 of INM common shares; the shares will be issued at a purchase price of $3.30 per share or prefunded warrant. In addition, the agreement notes that INM will issue unregistered preferred investment options to the same investors; those options include purchasing up to 3,272,733 additional common shares. According to the announcement, the company anticipates the private placement, which…

Continue Reading